Key Takeaways
- • Pepeto, an Ethereum-based token, is in its final presale stages ahead of a reported Binance listing, with investor demand driving a record presale pace according to Pluang.
- • Pepeto positions itself as addressing problems Cardano aimed to fix, including high fees and network congestion, by offering zero-fee trades across multiple chains and AI-checked smart contracts.
- • Pluang reports Cardano (ADA) shows bullish signs with a potential 6x price increase by 2026, supported by growing real-world use and strong buying from large investors.
- • The article frames Pepeto's presale as a faster-return opportunity compared with Cardano's longer-term growth thesis, a promotional framing rather than an independent assessment.
Summary
Pluang reports that Ethereum-based token Pepeto is in the final stages of its presale ahead of a planned listing on Binance, with rapid investor interest driving what the article describes as a record presale pace. The article positions Pepeto as a solution to problems Cardano (ADA) has aimed to address, including high transaction fees and network congestion. According to the piece, Pepeto offers zero-fee trades across multiple chains and AI-checked smart contracts.
The same article forecasts that Cardano could rise 6x in price by 2026, citing growing real-world use and strong buying from large investors. It frames Pepeto's early-stage entry as appealing to investors seeking faster returns relative to Cardano's longer-term growth potential. These claims are promotional in nature and are not independently verified in the source material; no audited data on presale size, token distribution, or exchange listing confirmation is provided.
The article also includes a brief US equities snapshot as of Oct 20, 2026 00:41 WIB: of 150 priced US stocks, 53 rose and 94 fell. Notable movers cited were Novavax (NVAX) at USD 10.84, down 3.73%, Snowflake (SNOW) at USD 317.73, up 3.55%, and Moderna (MRNA) at USD 225.46, up 3.42%. These market figures are unrelated to the crypto story and are included in the source as general market context.
The same article forecasts that Cardano could rise 6x in price by 2026, citing growing real-world use and strong buying from large investors. It frames Pepeto's early-stage entry as appealing to investors seeking faster returns relative to Cardano's longer-term growth potential. These claims are promotional in nature and are not independently verified in the source material; no audited data on presale size, token distribution, or exchange listing confirmation is provided.
The article also includes a brief US equities snapshot as of Oct 20, 2026 00:41 WIB: of 150 priced US stocks, 53 rose and 94 fell. Notable movers cited were Novavax (NVAX) at USD 10.84, down 3.73%, Snowflake (SNOW) at USD 317.73, up 3.55%, and Moderna (MRNA) at USD 225.46, up 3.42%. These market figures are unrelated to the crypto story and are included in the source as general market context.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.